121 related articles for article (PubMed ID: 9852402)
1. Estrogen dependency in uterine endometrial cancers.
Fujimoto J; Hirose R; Sakaguchi H; Tamaya T
Oncology; 1998 Dec; 55 Suppl 1():53-9. PubMed ID: 9852402
[TBL] [Abstract][Full Text] [Related]
2. [Endocrinological contribution for invasion and metastasis in gynecological cancers].
Fujimoto J
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):633-43. PubMed ID: 8808831
[TBL] [Abstract][Full Text] [Related]
3. Steroid receptors and metastatic potential in endometrial cancers.
Fujimoto J; Sakaguchi H; Aoki I; Tamaya T
Eur J Cancer; 2000 Sep; 36 Suppl 4():S33. PubMed ID: 11056308
[TBL] [Abstract][Full Text] [Related]
4. Estrogen and progesterone receptor structure and action in breast cancer cells.
Bettuzzi S; Robinson A; Fuchs-Young R; Greene GL
Cancer Treat Res; 1992; 61():301-15. PubMed ID: 1360239
[No Abstract] [Full Text] [Related]
5. Characterization and regulation of estrogen and progesterone receptors in breast cancer.
Read LD; Katzenellenbogen BS
Cancer Treat Res; 1992; 61():277-99. PubMed ID: 1360237
[No Abstract] [Full Text] [Related]
6. Steroid receptors and metastatic potential in endometrial cancers.
Fujimoto J; Sakaguchi H; Aoki I; Khatun S; Toyoki H; Tamaya T
J Steroid Biochem Mol Biol; 2000 Dec; 75(4-5):209-12. PubMed ID: 11282273
[TBL] [Abstract][Full Text] [Related]
7. HER-2/neu overexpression and hormone dependency in endometrial cancer: analysis of cohort and review of literature.
Mariani A; Sebo TJ; Katzmann JA; Riehle DL; Dowdy SC; Keeney GL; Lesnick TG; Podratz KC
Anticancer Res; 2005; 25(4):2921-7. PubMed ID: 16080545
[TBL] [Abstract][Full Text] [Related]
8. Effect of estrogen sulfation by SULT1E1 and PAPSS on the development of estrogen-dependent cancers.
Xu Y; Liu X; Guo F; Ning Y; Zhi X; Wang X; Chen S; Yin L; Li X
Cancer Sci; 2012 Jun; 103(6):1000-9. PubMed ID: 22380844
[TBL] [Abstract][Full Text] [Related]
9. Sex steroids in uterine endometrial cancers.
Fujimoto J; Sato E
Horm Mol Biol Clin Investig; 2011 Mar; 5(3):143-51. PubMed ID: 25961249
[TBL] [Abstract][Full Text] [Related]
10. Sex steroid-dependent angiogenesis in uterine endometrial cancers.
Fujimoto J; Toyoki H; Jahan I; Alam SM; Sakaguchi H; Sato E; Tamaya T
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):161-5. PubMed ID: 15860258
[TBL] [Abstract][Full Text] [Related]
11. Role of estrogen and estrogen-related growth factor in the mechanism of hormone dependency of endometrial carcinoma cells.
Hata H; Hamano M; Watanabe J; Kuramoto H
Oncology; 1998 Dec; 55 Suppl 1():35-44. PubMed ID: 9852400
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of analysis of estrogen and progesterone receptors in human uterine tissues].
Maleeva A; Milkov V
Akush Ginekol (Mosk); 1991 May; (5):55-7. PubMed ID: 1897675
[TBL] [Abstract][Full Text] [Related]
13. Role of bcl-2 in endometrioid corpus cancer: an experimental study.
Mariani A; Sebo TJ; Cliby WA; Keeney GL; Riehle DL; Lesnick TG; Podratz KC
Anticancer Res; 2006; 26(2A):823-7. PubMed ID: 16619475
[TBL] [Abstract][Full Text] [Related]
14. K-Ras stabilization by estrogen via PKCδ is involved in endometrial tumorigenesis.
Koo KH; Jeong WJ; Cho YH; Park JC; Min do S; Choi KY
Oncotarget; 2015 Aug; 6(25):21328-40. PubMed ID: 26015399
[TBL] [Abstract][Full Text] [Related]
15. Clinical implication of estrogen-related receptor (ERR) expression in uterine endometrial cancers.
Fujimoto J; Sato E
J Steroid Biochem Mol Biol; 2009 Aug; 116(1-2):71-5. PubMed ID: 19416752
[TBL] [Abstract][Full Text] [Related]
16. Molecular tools to reestablish progestin control of endometrial cancer cell proliferation.
Dai D; Kumar NS; Wolf DM; Leslie KK
Am J Obstet Gynecol; 2001 Apr; 184(5):790-7. PubMed ID: 11303185
[TBL] [Abstract][Full Text] [Related]
17. Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer.
Smuc T; Rizner TL
Mol Cell Endocrinol; 2009 Mar; 301(1-2):74-82. PubMed ID: 18930784
[TBL] [Abstract][Full Text] [Related]
18. Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma.
Engelsen IB; Mannelqvist M; Stefansson IM; Carter SL; Beroukhim R; Øyan AM; Otte AP; Kalland KH; Akslen LA; Salvesen HB
Br J Cancer; 2008 May; 98(10):1662-9. PubMed ID: 18475299
[TBL] [Abstract][Full Text] [Related]
19. Expression of uteroglobin in normal and carcinogenic endometrium and influence of hormone replacement therapy.
Tanaka R; Saito T; Shijubo N; Takehara M; Yamada G; Kawabata I; Itoh Y; Kudo R
Int J Cancer; 2004 Mar; 109(1):43-8. PubMed ID: 14735466
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of the expression of estrogen receptor-alpha and -beta in primary and metastatic lesions of uterine endometrial cancers.
Fujimoto J; Sakaguchi H; Aoki I; Toyoki H; Tamaya T
Oncology; 2002; 62(3):269-77. PubMed ID: 12065875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
